General Surgical Innovations forms cardiovascular distribution deals:
This article was originally published in Clinica
General Surgical Innovations has signed exclusive distribution agreements for its range of cardiovascular products in the UK, Germany, Belgium, Holland, Italy, Portugal, Spain. The agreements with unnamed distributors include its Endosaph system for the minimally-invasive harvesting of the saphenous vein and the surgical balloon dissector for subfascial endoscopic perforator surgery. The company has a direct sales force in the US and sells in Japan through an exclusive distribution agreement.
You may also be interested in...
If J&J’s gamble on a single dose pays off, it could rapidly advance the fight against SARS-CoV2 – but a second study will provide a safety net.
Agency has been prepping Woodcock for the temporary task but what will happen to her role on Operation Warp Speed remains unclear. The move should give Biden team cushion to confirm a permanent leader of whom a top contender is former senior FDA staffer Joshua Sharfstein, a proponent of drug reforms that may irk manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.